BB-1101

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameBB-1101

Drug Alias NameN/A

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionPeptide hydrolase inhibitorsTumor necrosis factor inhibitorsMetalloproteases inhibitors

TargetsMetalloproteasesTumor necrosis factorPeptide hydrolase

Therapy Area/IndicationsRheumatic DiseasesEncephalomyelitis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBritish Biotech

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBritish Biotech

Active IndicationsN/A

Inactive IndicationsRheumatic DiseasesEncephalomyelitis

ATC CodeN/A